Colombia vs Guinea: Access to anti-retroviral drugs, male
Colombia
64.0%
in 2023
Guinea
64.0%
in 2024
Colombia rank
87th
Guinea rank
87th
Access to anti-retroviral drugs, male over time
- Colombia
- Guinea
How they compare
Colombia currently reports 64.0% against 64.0% in Guinea, a difference of 0.0%.
The two have swapped places 3 times across 24 shared years of data; in 2000 it was Guinea ahead.
Colombia ranks 87th and Guinea ranks 87th of 141 countries.
Colombia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.6% | 4.6% | 1.0% | Colombia |
| 2010s | 34.1% | 26.9% | 7.2% | Colombia |
| 2020s | 60.2% | 48.0% | 12.2% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Colombia or Guinea?
- Colombia, at 64.0% against 64.0% in Guinea as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Colombia and Guinea?
- 0.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Guinea?
- 24 years are reported by both, from 2000 to 2023.
- How do Colombia and Guinea rank globally for access to anti-retroviral drugs, male?
- Colombia ranks 87th and Guinea ranks 87th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.